Omada Health, Inc. (OMDA) CEO sells 12,944 shares after option exercise
Rhea-AI Filing Summary
Omada Health, Inc. CEO Sean P. Duffy exercised stock options for 12,944 shares of common stock at $5.82 per share and on the same day sold 12,944 shares at a weighted average price of $20.3961 in open-market transactions between $20.15 and $20.58. The sale was executed under a Rule 10b5-1 trading plan adopted March 13, 2026. After the exercise, he held 142,483 options and 851,659 common shares indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 12,944 shares ($189K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Duffy Sean P.
Role
Chief Executive Officer
Sold
12,944 shs ($264K)
Approx. gross sale proceeds
$264K
Approx. exercise cost
$75K
Approx. pre-tax spread
$189K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F4 | 12,944 | $0.00 | $0.00 |
| Exercise | Common Stock | 12,944 | $5.82 | $75K |
| Sale | Common Stock F1, F2 | 12,944 | $20.3961 | $264K |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 142,483 shares (Direct);
Common Stock — 411,861 shares (Direct);
Common Stock — 851,659 shares (Indirect, See footnote)
Footnotes (4)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $20.15 to $20.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
- F4. 100% of the shares subject to the option are fully vested and exercisable.
Key Figures
Shares sold: 12,944 shares
Sale price (weighted average): $20.3961 per share
Options exercised: 12,944 shares at $5.82
+3 more
6 metrics
Shares sold
12,944 shares
Common stock sold on 2026-08-03 in open-market transactions under a Rule 10b5-1 plan
Sale price (weighted average)
$20.3961 per share
Weighted average sale price, with individual trades ranging from $20.15 to $20.58
Options exercised
12,944 shares at $5.82
Stock options exercised at $5.82 per share on 2026-08-03 to acquire common stock
Options remaining
142,483 options
Stock options remaining after exercising 12,944-option portion of an already fully vested grant
Indirect common shares
851,659 shares
Common stock held indirectly in family trusts, with beneficial ownership disclaimed except for pecuniary interest
Option expiration
2029-08-21
Expiration date of the stock option from which 12,944 shares were exercised
Key Terms
Rule 10b5-1 trading plan, weighted average price, pecuniary interest, Stock Option (Right to Buy), +1 more
5 terms
Rule 10b5-1 trading plan financial
"Transaction made pursuant to a 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest financial
"disclaims beneficial ownership except to the extent of his pecuniary interest"
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) reported as derivative"
indirect ownership financial
"Common Stock entry marked indirect, held in family trusts"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Omada Health (OMDA) CEO Sean P. Duffy report in this Form 4?
Sean P. Duffy reported an exercise-and-sell transaction involving 12,944 Omada Health shares. He exercised stock options at $5.82 per share to acquire 12,944 common shares, then sold the same number at a $20.3961 weighted average price in open-market trades.
What stock options did Sean P. Duffy exercise in Omada Health (OMDA)?
He exercised options covering 12,944 shares of Omada Health common stock at an exercise price of $5.82 per share. The underlying option was fully vested and exercisable, with an expiration date of August 21, 2029, before he completed the reported sale.
What Omada Health (OMDA) holdings does Sean P. Duffy report after these transactions?
After the transactions, he reported holding 142,483 stock options directly and 851,659 common shares indirectly through family trusts. He disclaims beneficial ownership of the trust-held shares except to the extent of his pecuniary interest, reflecting limited economic attribution to him personally.
Were Sean P. Duffy’s Omada Health (OMDA) trades made under a Rule 10b5-1 plan?
Yes. The reported sale of 12,944 shares was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. The filing also checks the Rule 10b5-1 box, indicating the transactions were executed according to a pre-arranged trading plan rather than discretionary timing.